Skip to main content

Advertisement

SpringerLink
Log in

Economic impact of chronic prostatitis

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

There are four types of prostatitis, including type I (acute bacterial prostatitis), type II (chronic bacterial prostatitis), type III (chronic prostatitis/chronic pelvic pain syndrome, or CP/CPPS), and type IV (asymptomatic inflammatory prostatitis). These prostatitis conditions account for approximately 2 million office visits each year to primary care physicians and urologists. The annual cost to treat prostatitis is approximately $84 million. Compared with control subjects, men with prostatitis incur significantly greater costs, predominantly due to increased outpatient visits and pharmacy expenses. CP/CPPS is the most common type of prostatitis. The condition is characterized by chronic, idiopathic pelviperineal pain. Due to the lack of effective treatments for CP/CPPS, the per-person costs associated with the condition are substantial and are similar to those reported for peripheral neuropathy, low back pain, fibromyalgia, and rheumatoid arthritis. Costs appear to be higher in men with more severe symptoms. Indirect costs (eg, work and productivity loss) are incurred by many patients with CP/CPPS. Identification of effective treatments for CP/CPPS would be expected to substantially reduce the costs associated with the condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236–237.

    Article  PubMed  CAS  Google Scholar 

  2. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, et al.: Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community. J Urol 2005, 174:2319–2322.

    Article  PubMed  Google Scholar 

  3. Collins MM, Stafford RS, O’Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224–1228.

    Article  PubMed  CAS  Google Scholar 

  4. Roberts RO, Lieber MM, Rhodes T, et al.: Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998, 51:578–584.

    Article  PubMed  CAS  Google Scholar 

  5. Mehik A, Hellstrom P, Lukkarinen O, et al.: Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 2000, 86:443–448.

    Article  PubMed  CAS  Google Scholar 

  6. Collins MM, Meigs JB, Barry MJ, et al.: Prevalence and correlates of prostatitis in the Health Professionals Follow-Up Study cohort. J Urol 2002, 167:1363–1366.

    Article  PubMed  Google Scholar 

  7. Moon TD: Questionnaire survey of urologists and primary care physicians’ diagnostic and treatment practices for prostatitis. Urology 1997, 50:543–547.

    Article  PubMed  CAS  Google Scholar 

  8. Cheah PY, Liong ML, Yuen KH, et al.: Chronic prostatitis: symptom survey with follow-up clinical evaluation. Urology 2003, 61:60–64.

    Article  PubMed  Google Scholar 

  9. Nickel JC, Downey J, Hunter D, Clark J: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001, 165:842–845.

    Article  PubMed  CAS  Google Scholar 

  10. Roberts RO, Jacobson DJ, Girman CJ, et al.: Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol 2002, 168:2467–2471.

    Article  PubMed  Google Scholar 

  11. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, et al.: Analysis of medical costs in men diagnosed with prostatitis. J Urol Suppl 2006, 175:32.

    Google Scholar 

  12. McNaughton-Collins M, Joyce GF, Wise M, Pontari MA: Prostatitis. In Urologic Diseases in America. Edited by Litwin MS, Saigal CS. NIH publication no. 07-5512. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Publishing Office; 2007:11–39.

    Google Scholar 

  13. Turner JA, Ciol MA, Von Korff M, et al.: Healthcare use and costs of primary and secondary care patients with prostatitis. Urology 2004, 63:1031–1035.

    Article  PubMed  Google Scholar 

  14. Calhoun EA, McNaughton Collins M, Pontari MA, et al.: The economic impact of chronic prostatitis. Arch Intern Med 2004, 164:1231–1236.

    Article  PubMed  Google Scholar 

  15. National health expenditures aggregate and per capita amounts, percent distribution and average annual percent change by source of funds: selected calendar years 1980–2011. Available at http://www.cms.hhs.gov/NationalHealthExpend-Data. Accessed February 5, 2007.

  16. Clemens JQ, Brown SO, Calhoun EA: Comparison of the economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome. Presented at the American Urological Association meeting. Anaheim, CA; May 19–23, 2007

Download references

Author information

Authors and Affiliations

  1. Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL, 60611, USA

    J. Quentin Clemens

Authors
  1. Anna M. S. Duloy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth A. Calhoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Quentin Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Quentin Clemens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duloy, A.M.S., Calhoun, E.A. & Clemens, J.Q. Economic impact of chronic prostatitis. Curr Urol Rep 8, 336–339 (2007). https://doi.org/10.1007/s11934-007-0081-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-007-0081-x

Keywords

Search

Navigation